Variant report
Variant | nsv962446 |
---|---|
Chromosome Location | chr17:50577064-50583145 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72841075 | chr17:50577260-50577261 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs59513297 | chr17:50577306-50577307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568610987 | chr17:50577311-50577312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531961179 | chr17:50577321-50577322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548697029 | chr17:50577366-50577367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551792455 | chr17:50577392-50577393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567292931 | chr17:50577404-50577405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527954236 | chr17:50577414-50577415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547778599 | chr17:50577443-50577444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567807800 | chr17:50577458-50577459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535191646 | chr17:50577483-50577484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187800910 | chr17:50577487-50577488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570196770 | chr17:50577503-50577504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34608133 | chr17:50577515-50577516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536056199 | chr17:50577545-50577546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192157025 | chr17:50577580-50577581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12601722 | chr17:50577597-50577598 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs372875279 | chr17:50577620-50577621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534874614 | chr17:50577644-50577645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554606519 | chr17:50577659-50577660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12601737 | chr17:50577694-50577695 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs543282401 | chr17:50577729-50577730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563383938 | chr17:50577761-50577762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184673960 | chr17:50577776-50577777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545518990 | chr17:50577817-50577818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138267293 | chr17:50577853-50577854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs41431048 | chr17:50577867-50577868 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
28 | rs36024840 | chr17:50577889-50577890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10515018 | chr17:50577892-50577893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs566376810 | chr17:50577897-50577898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9303599 | chr17:50577944-50577945 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs369262687 | chr17:50577979-50577980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554653118 | chr17:50577994-50577995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116733351 | chr17:50577999-50578000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371927655 | chr17:50578018-50578019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12600373 | chr17:50578019-50578020 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs558972675 | chr17:50578043-50578044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576931670 | chr17:50578064-50578065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552711183 | chr17:50578130-50578131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs117477084 | chr17:50578199-50578200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544756350 | chr17:50578327-50578328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78215705 | chr17:50578330-50578331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146102579 | chr17:50578368-50578369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568299979 | chr17:50578440-50578441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75137400 | chr17:50578468-50578469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75614134 | chr17:50578510-50578511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189539145 | chr17:50578665-50578666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545452558 | chr17:50578681-50578682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542940775 | chr17:50578785-50578786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552691883 | chr17:50578792-50578793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Chordoma | 18071362 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:50577200-50577800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr17:50577800-50582400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr17:50582400-50583400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr17:50582600-50583000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
5 | chr17:50582600-50583400 | Enhancers | Skeletal Muscle Male | skeletal muscle |